Emma Hockly

2.0k total citations · 1 hit paper
12 papers, 1.6k citations indexed

About

Emma Hockly is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Emma Hockly has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Emma Hockly's work include Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (7 papers) and Neurological disorders and treatments (6 papers). Emma Hockly is often cited by papers focused on Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (7 papers) and Neurological disorders and treatments (6 papers). Emma Hockly collaborates with scholars based in United Kingdom, United States and Germany. Emma Hockly's co-authors include Gillian P. Bates, Amarbirpal Mahal, Cathryn M. Lewis, Kirupa Sathasivam, Shabnam Ghazi‐Noori, Donna L. Smith, Philip A. S. Lowden, Eddie Rosa, Victoria M. Richon and Joan Marsh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Neurology and Human Molecular Genetics.

In The Last Decade

Emma Hockly

12 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

2003 667 citations Emma Hockly, Victoria M. Richon et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma Hockly United Kingdom	9	1.2k	1.1k	379	175	99	12	1.6k
Eric N. Burright United States	14	1.4k 1.2×	1.3k 1.2×	299 0.8×	213 1.2×	77 0.8×	20	1.7k
Paola Conforti Italy	18	951 0.8×	694 0.6×	230 0.6×	147 0.8×	93 0.9×	29	1.2k
Hélène Rangone United Kingdom	11	1.3k 1.1×	1.2k 1.1×	321 0.8×	124 0.7×	110 1.1×	12	1.7k
Laure Jamot France	11	908 0.8×	946 0.9×	333 0.9×	83 0.5×	75 0.8×	17	1.3k
Cindy V. Ly United States	13	1.1k 0.9×	757 0.7×	254 0.7×	83 0.5×	254 2.6×	22	1.6k
Tammy Gillis United States	22	1.5k 1.3×	1.3k 1.2×	506 1.3×	210 1.2×	190 1.9×	36	1.9k
Craig Meyers United States	19	740 0.6×	479 0.4×	289 0.8×	255 1.5×	182 1.8×	33	1.4k
Rose E. Goodchild Belgium	18	928 0.8×	1.1k 1.0×	1.1k 2.8×	132 0.8×	233 2.4×	25	2.2k
Osamu Komure Japan	17	612 0.5×	809 0.7×	646 1.7×	96 0.5×	212 2.1×	32	1.3k
Yijun Cui United States	8	496 0.4×	447 0.4×	297 0.8×	196 1.1×	88 0.9×	10	1.0k

Countries citing papers authored by Emma Hockly

Since Specialization

Citations

This map shows the geographic impact of Emma Hockly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Hockly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Hockly more than expected).

Fields of papers citing papers by Emma Hockly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Hockly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Hockly. The network helps show where Emma Hockly may publish in the future.

Co-authorship network of co-authors of Emma Hockly

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Hockly. A scholar is included among the top collaborators of Emma Hockly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Hockly. Emma Hockly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Woodman, Ben, Rachel Butler, Christian Landles, et al.. (2006). The HdhQ150/Q150 knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Research Bulletin. 72(2-3). 83–97. 131 indexed citations

2.

Benn, Caroline, Christian Landles, Li He, et al.. (2005). Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease. Human Molecular Genetics. 14(20). 3065–3078. 99 indexed citations

3.

Hockly, Emma, Hilary Moffitt, Kirupa Sathasivam, et al.. (2005). Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease. Neurobiology of Disease. 21(1). 228–236. 60 indexed citations

4.

Hockly, Emma, Victoria M. Richon, Donna L. Smith, et al.. (2003). Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences. 100(4). 2041–2046. 667 indexed citations breakdown →

5.

Hockly, Emma, et al.. (2003). Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain Research Bulletin. 61(5). 469–479. 110 indexed citations

6.

Smith, Donna L., Amarbirpal Mahal, Kirupa Sathasivam, et al.. (2003). Minocycline and doxycycline are not beneficial in a model of Huntington's disease. Annals of Neurology. 54(2). 186–196. 131 indexed citations

7.

Bates, Gillian P. & Emma Hockly. (2003). Experimental therapeutics in Huntington's disease. Current Opinion in Neurology. 16(4). 465–470. 40 indexed citations

8.

Bates, Gillian P. & Emma Hockly. (2003). . Current Opinion in Neurology. 16(4). 465–470. 2 indexed citations

9.

Hockly, Emma, et al.. (2003). Reply. Annals of Neurology. 54(6). 842–843. 2 indexed citations

10.

Goodman, Nathan, Kim M. McCormick, Dan Goldowitz, et al.. (2003). Plans for HDBase—a research community website for Huntington's Disease. Clinical Neuroscience Research. 3(3). 197–217. 4 indexed citations

11.

Hockly, Emma, Patricia M. Cordery, Amarbirpal Mahal, et al.. (2002). Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Annals of Neurology. 51(2). 235–242. 265 indexed citations

12.

Smith, Donna L., R Portier, Ben Woodman, et al.. (2001). Inhibition of Polyglutamine Aggregation in R6/2 HD Brain Slices—Complex Dose–Response Profiles. Neurobiology of Disease. 8(6). 1017–1026. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact